Hans Hull, Chief Business Officer: Pliant Therapeutics PLRX Sell · Filed 24/01/19

Trade details

Type: Insider sale
Amount: $168,612.78
Shares · price: 9,786 sh · $17.23 a share
Held after: 185,069 sh
Stock: Pliant Therapeutics PLRX
Person: Hans HullChief Business Officer
Trade date: 24/01/17
Filed: 24/01/19
Days to filing: 2 days

Sold 5.0% of holdings

Share of holding sold: 5.0%

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/18~24/02/16

Hans Hull's recent trades

Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$178.5K
15,936 sh
$178.5K
Filed 25/01/22
Traded 25/01/17
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$114.4K
9,900 sh
$114.4K
Filed 24/07/12
Traded 24/07/10
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$401.2K
20,050 sh
$401.2K
Filed 23/08/07
Traded 23/08/04
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$261.4K
13,069 sh
$261.4K
Filed 23/08/07
Traded 23/08/03
Hans HullChief Business Officer
Sell10b5-1 planPliant Therapeutics
Sell10b5-1 plan
Pliant Therapeutics
PLRX
$36K
1,800 sh
$36K
Filed 23/08/07
Traded 23/08/03